The ramifications of the U.S. Supreme Court’s decision Feb. 20 that shot down President Donald Trump’s reciprocal tariffs issued under the International Emergency Economic Powers Act are rippling ...

U.S. FDA approvals began 2026 at a slower pace than usual, with eight approvals recorded in January. The total falls below the 2025 monthly average of about 19 approvals and trails every month last ...

For more than 40 years, investors have trusted Morningstar to tell it like it is. Our independent analysis and investment research tools uncover how well an investment serves investors—and no one else ...